CDEK
← All organizations

Orion Corporation

For profitContributed to NMEWebsite ↗

Also known as: Orion Corporation, OrionPharma | Orion Corporation, Orion Pharma | Orion Corporation, Orion Pharma, Development | Orion Corporation provides financial support. | ORION PHARMA | Orion Pharma Clinical Pharmacology Unit, Espoo, Finland | Orion Pharma, Clinical Pharmacology Unit, Espoo, Finland | Orion Pharma, Espoo, Finland | Orion Pharma R&D Nottingham England

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2002

First marketed drug

Oct 19, 1999

First NDA

Dec 30, 1999

Last known activity

Sep 19, 2024

Timeline

1910s

  1. Jan 1, 1917

    Orion Corporation— Founded

1990s

  1. Oct 19, 1999

    entacapone— NDA Secondary Org

  2. Dec 30, 1999

    entacapone— NDA Organization

2000s

  1. Jun 11, 2003

    levodopa— Marketing Organization

Drugs by trial phase (67 distinct, 127 trials)

Other trials (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (3)

Recent trials (50)

Details

Founded
Espoo, FI Jan 1, 1917
First NDA
Dec 30, 1999
Last known activity
Sep 19, 2024